Chronisch entzündliche Darmerkrankungen – Transition von der Jugend- zur Erwachsenenmedizin

Zusammenfassung

Chronisch entzündliche Darmerkrankungen stellen für Jugendliche und Adoleszenten ein erhebliches Entwicklungsrisiko sowie eine Beeinträchtigung ihrer Lebensqualität und ihrer Chancen für die Persönlichkeitentfaltung dar. Besonders nach einer Manifestation der CED in der frühen Kindheit ist ein zielgerichteter, geplanter und koordinierter Übergang (Transition) eine conditio sine qua non für die Kontrolle der Krankheit. Die unterschiedlichen Betreuungssysteme in der Kinder- und Jugend- als auch in der Erwachsenenmedizin werden zunehmend mit der Aufgabe konfrontiert, die Transition als wichtigen Teil der medizinischen Behandlung aufzufassen und sie erfolgreich zu realisieren.

Abstract

Children and adolescents with inflammatory bowel diseases (IBD) are a group of patients with increasingly special health care needs. Transition from a pediatric and adolescent healthcare system into an adult medicine setting may be difficult but nevertheless is very important to ensure physiological development of adolescent patients and of the continuity of their medical treatment. Transition has shown to be a challenge for pediatricians and adult doctors as well. In Germany within the healthcare system there are no special structures established to organize and optimize transition. The German Society for Pediatric Gastroenterology and Nutrition and the German Society of Internal Medicine have founded a working group to proceed the process of transition of young patients with IBD within the german helth care.

Schlüsselwörter

Kindergastroenterologie - chronisch entzündliche Darmerkrankungen - Jugendmedizin - Transition

Key Words

pediatric gastroenterology - inflammatory bowel diseases - adolescent medicine - transition

• Literaturverzeichnis

• 1 Blum RW, Garell D, Hodgman CH et al. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health 1993; 14: 570-576
• 2 Keller KM. Transition bei Jugendlichen mit CED. Monatsschr Kinderheilkd 2010; 158: 738-744
• 3 Levine A, Koletzko S, Turner D et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J ­Pediatr ­Gastroenterol Nutr 2014; 58: 795-806
• 4 Malaty HM, Fan X, Opekun AR et al. Rising incidence of inflammatory bowel diseases among children: a 12 year study. J Pediatr Gastroenterol Nutr 2010; 50: 27-31
• 5 Benchimol EI, Fortinsky KJ, Gozdyra P et al. Epidemio­logy of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-439
• 6 Aloi M, D’Arcangelo G, Pofi F et al. Presenting features and disease course of pediatric ulcerative colitis. J Crohns Colitis 2013; 7: e509-515
• 7 Malaty HM, Mehta S, Abraham B et al. The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period. Clin Exp Gastroenterol 2013; 6: 115-121
• 8 Ruemmele FM, Turner D. Differences in the management of pediatric and adult onset ulcerative colitis – lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis. J Crohns Colitis 2014; 8: 1-4
• 9 Ruemmele FM, Veres G, Kolho KL et al. Consensus guidelines of ECCO / ESPGHAN on the medical management of pediatric Crohn’s disease. J ­Crohns ­Colitis 2014; 8: 1179-1207
• 10 IBD Working Group of the ESPGHAN. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis – the Porto criteria. J ­Pediatr ­Gastroenterol Nutr 2005; 41: 1-7
• 11 Schmidt C, Herrlinger K, Siegmund B et al. Azathioprin in der Therapie des Morbus Crohn – eine Standort­bestimmung vor dem Hintergrund aktueller Studien. Z Gastroenterol 2014; 52: 1423-1430
• 12 Markowitz J, Grancher K, Kohn N et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn’s disease. ­Gastroenterology 2000; 119: 895-902
• 13 Pigneur B, Seksik P, Viola S et al. Natural history of Crohn’s disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis 2010; 16: 953-961
• 14 Szigethy E, Craig AE, Iobst EA et al. Profile of depression in adolescents with inflammatory bowel disease: implications for treatment. Inflamm Bowel Dis 2009; 15: 69-74
• 15 Müther S, Rodeck B, Wurst C et al. Transition von Jugendlichen mit chronischen Erkrankungen in die Erwachsenenmedizin. Monatsschr Kinderheilkd 2014; 162: 711-718
• 16 Hait EJ, Barendse RM, Arnold JH et al. Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr 2009; 48: 61-65
• 17 Philpott JR. Transitional care in inflammatory bowel disease. Gastroenterol Hepatol (NY) 2011; 7: 26-32
• 18 Goodhand J, Hedin CR, Croft NM et al. Adolescents with IBD: the importance of structured transition care. J Crohns Colitis 2011; 5: 509-519
• 19 Leung Y, Heyman MB, Mahadevan U. Transitioning the Adolescent inflammatory bowel disease patient: Guidelines fort he adult and the pediatric gastroenterologisst. Inflamm Bowel Dis 2011; 17: 2169-2173
• 20 Claßen M, Kretzschmar B, Kretzschmar A et al. Schulung für Kinder und Jugendliche mit chronisch entzündlichen Darmerkrankungen. Lengerich: Pabst Science Publishers; 2014. http://www.pabst-publishers.de/Medizin/buecher/images/modus_9783899679038.pdf (01. 12. 2014)
• 21 Izaguirre MR, Keefer L. Development of a self-efficacy scale for adolescents and young adults with inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2014; 59: 29-32
• 22 Sebastian S, Jenkins H, McCartney S et al. The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric gastroenterologists. J Crohns Colitis 2012; 6: 830-844